Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. Tutt ANJ, Garber JE, Kaufman B, Viale G, et al. N Engl J Med 2021 Jun 3. doi: 10.1056/NEJMoa2105215.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tutt ANJ, Garber JE, Kaufman B, Viale G, et al. Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. N Engl J Med 2021 Jun 3. doi: 10.1056/NEJMoa2105215.
PMID: 34081848